Work

Abstract CT176: Pharmacokinetics (PK) of the novel nonsteroidal CYP11A1 inhibitor opevesostat (ODM-208/MK-5684): Interaction potential with midazolam and effect of food

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct176

Authors: Natalie Cook, Jan de Hoon, Arif Hussain, Robert H. Jones, Robert J. Jones, Alice Bernard-Tessier, Ruiyang Yan, Magdalena Meissner, Tarja Naukkarinen, Jonathan Belman, Zhiqing Xu, An Bautmans, Aubrey Stoch, Virpi Mononen, Pasi Pohjanjousi, Chris Garratt, Christian Poehlein, Karim Fizazi

Institutions: University of Manchester, The Christie NHS Foundation Trust, KU Leuven, Velindre NHS Trust, Beatson West of Scotland Cancer Centre, University of Glasgow, Université Paris-Saclay, Institut Gustave Roussy, Orion Corporation (Finland), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822087

Cites:

Cited by:

Related to: 10